Grant

A Randomized, Open Label Phase 3 Study Evaluating Safety and Efficacy of Venetoclax in combination with Azacitidine after allogeneic Stem Cell Transplantation in Subjects with Acute Myeloid Leukemia

Sponsored by AbbVie Incorporated

Active

$2.4M Funding

3 People

External

Related Topics

stem cell transplantation, acute myeloid leukemia, venetoclax, azacitidine, efficacy and safety

People

Francois Chu
(CD)
Cancer Center Division﹒Research Compliance Administrator I
Ravitharan Krishnadasan
Co-Investigator (COI)
Medicine﹒Clinical Professor, Medicine - (Clinical Series Track)
Sharad Khurana
Principal Investigator (PI)
Medicine﹒Assistant Professor, Medicine - (Clinical Scholar Track)